Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the ...
Circulating Tumor Cell (CTC) Market Analysis and Forecast 2025-2030: Reshaping Oncology with Innovations in Cancer Diagnostics
Key Players to WatchDublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & ...
AZoSensors1d
Researchers Develop Fast-Acting Sensors to Detect Antibiotic-Resistant Bacteria
Antibiotic resistance is a growing threat. Empa's innovative sensors offer rapid detection of resistant pathogens, improving ...
News-Medical.Net1d
Northwestern scientists develop rapid HIV test for point-of-care diagnosis
A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the ...
News-Medical.Net2d
NIH funds research to develop a game-changing HIV diagnostic tool
As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...
Lowenthal & Abrams Expands focus on Medical Malpractice in Pittsburgh and Western Pennsylvania as Misdiagnosis Cases Soar
Lowenthal & Abrams expands medical malpractice advocacy in Pittsburgh and Western PA, fighting for victims of misdiagnosis ...
Adicon Is One of the Largest Independent Clinical Laboratories, With Ample Room for Growth
We believe Adicon has a manageable financial situation. As of December 2024, it has CNY 768 million cash in hand and a total debt of CNY 1.0 billion. Its debt/capital ratio was 42.4% by the end of ...
Le Lézard3d
TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer
Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
Le Lézard6d
Cytogenetics Market Projected to Reach $5.5 Billion by 2031, Growing at a CAGR of 9.6% from 2024 --Exclusive Report by Meticulous Research®
According to a new market research report titled 'Cytogenetics Market Size, Share, Forecast, & Trends Analysis by Product (Instruments, Consumables, Software & Services), Technique (Karyotyping, FISH, ...